NECKEPUR is a deeptech company founded in 2022, following 5 years of intensive and successful research on the interaction of drugs with medical devices. NECKEPUR leverages patented technology to develop innovative method & filters capable of selectively removing targeted substances.

The NECKEPUR team has already published nearly 20 international publications supporting Proof of Concept and Clinical Validation of its method.

This capability enables the company to offer a wide range of applications, addressing critical medical and environmental challenges, from blood to water filtrations, empowered by AI.

We are using our unique and patented in vitro method to develop new strategies to specifically capture contaminants and unwanted molecules in the blood in collaboration with academic and industrial partners.